The GUIDE Model is a specialized Medicare program that provides comprehensive dementia care management for eligible Original Medicare beneficiaries living at home or in approved care communities. It covers care coordination, caregiver support, and respite services—plus Medicare Part B covers newer amyloid-targeting medications and cognitive assessments—but enrollment is limited to Original Medicare (not Medicare Advantage) and requires a confirmed dementia diagnosis. Beyond GUIDE, Medicare offers several pathways to dementia care: cognitive screening at no cost during annual wellness visits, coverage for in-home cognitive assessment and care planning, and access to newer medications like lecanemab and donanemab for early-stage disease. This guide explains eligibility, services, costs, and enrollment deadlines so you can act during open enrollment periods or determine whether GUIDE fits your situation.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Register through CMS’s official page — Use this page to review requirements and register directly.
- Medicare.gov Open Enrollment — Use this page to review requirements and register directly.
Table of Contents
- What is the GUIDE Model and who qualifies?
- What services and support does GUIDE cover?
- How do you enroll, and what are the 2026 deadlines?
- What newer medications does Medicare cover for dementia?
- What cognitive assessment and screening does Medicare cover?
- What happens when dementia advances to later stages?
- Frequently Asked Questions
What is the GUIDE Model and who qualifies?
The GUIDE Model—short for Guiding an Improved Dementia Experience—is an innovation program run by the Centers for medicare & Medicaid Services (CMS) that coordinates care specifically for people with dementia and their family caregivers. Unlike standard Medicare, which pays providers per visit, GUIDE bundles dementia-related services and pays healthcare teams to manage the whole care picture.
To qualify, you must meet specific requirements: enrolled in Medicare Parts A and B under Original Medicare (not Medicare Advantage), have a clinician-confirmed dementia diagnosis, and live in a private home or in a care community partnering with GUIDE. Your healthcare provider must participate in the program in your area. GUIDE is not available to all Medicare beneficiaries in all locations—availability depends on program sites near you.
What services and support does GUIDE cover?
GUIDE covers four core service areas: care management (assigning a care coordinator to your case), care coordination between doctors and specialists, structured caregiver education and support groups, and defined respite services so family caregivers can take breaks. Care coordination often means your team helps manage medications, schedules appointments, communicates between your doctors, and addresses safety concerns at home.
Caregiver support includes education about dementia, training for managing behavioral changes, and respite care—temporary care relief—though the scope of respite services varies by program location. You don't directly pay for these services; Medicare reimburses the care team through GUIDE's payment model. Out-of-pocket costs depend on whether you have supplemental coverage and any Part B cost-sharing.
How do you enroll, and what are the 2026 deadlines?
If you're newly eligible for Medicare at age 65, you have seven months centered on your birthday (three months before, the month of, and three months after) to enroll in Parts A and B. If you already have Original Medicare but want to know about GUIDE availability in your area, contact your local Medicare plan during open enrollment.
Medicare's annual Open Enrollment Period runs October 15 through December 7 each year. If you miss this window, General Enrollment opens January 1–March 31, though coverage starts the following month—a costly delay if you need immediate care. Check Medicare.gov's Open Enrollment plan comparison tool and search for GUIDE Model programs in your ZIP code.
What newer medications does Medicare cover for dementia?
Two recently approved monoclonal antibodies target amyloid, a protein linked to Alzheimer's disease: lecanemab (Leqembi) and donanemab (Kisunla). Medicare Part B covers both drugs for people with mild cognitive impairment or mild dementia who have documented amyloid evidence, provided your treating physician is enrolled in the required registry.
Cost-sharing is your responsibility: you pay 20% coinsurance of the Medicare-approved amount after you meet your Part B deductible, which is $240 for 2026. These are infusions given monthly or quarterly depending on the drug, so total costs can reach thousands per year before supplemental coverage helps. Neither drug is covered under Medicare Part D (prescription drug plans); Part B is where they're reimbursed.
What cognitive assessment and screening does Medicare cover?
All Medicare beneficiaries age 65+ receive a no-cost Annual Wellness Visit that includes cognitive impairment screening. This 15-minute check happens at your doctor's office and helps detect early signs of memory loss or thinking problems. If screening suggests concern, your doctor may order a more thorough assessment.
Medicare covers CPT code 99483—a comprehensive cognitive assessment lasting up to 60 minutes, including a written care plan—for any beneficiary with cognitive impairment, including Alzheimer's, other dementias, and mild cognitive impairment. This visit is billed separately and you pay standard Part B cost-sharing (20% after deductible). The assessment documents your baseline, guides treatment decisions, and establishes eligibility for programs like GUIDE.
What happens when dementia advances to later stages?
For people in advanced stages of dementia approaching end of life, Medicare covers hospice when an Alzheimer's patient meets specific criteria—typically Function Assessment Staging Test (FAST) level 7 or higher, plus certain medical conditions like aspiration pneumonia or inability to take fluids. Hospice is covered under Medicare Part A and focuses on comfort rather than curative treatment. Hospice eligibility is often complex because dementia alone doesn't always meet the "six-month prognosis" standard Medicare requires.
Your doctors and the hospice team work together to document readiness. Once enrolled, you receive nursing care, medications for comfort, counseling, and respite for family members—all without Part A or Part B cost-sharing. Discuss hospice options well before crisis; starting the conversation early with your care team and family clarifies values and timing.
Frequently Asked Questions
Can I use GUIDE if I have Medicare Advantage (Part C)?
No. GUIDE is available only to Original Medicare (Parts A and B) beneficiaries, which excludes roughly 42% of the Medicare population enrolled in Advantage plans. You would need to switch to Original Medicare during Open Enrollment to access GUIDE.
How much will lecanemab or donanemab cost me out of pocket?
After meeting your $240 Part B deductible for 2026, you pay 20% of the Medicare-approved amount for each infusion. Cost varies by local pricing and facility, but patients typically pay $500–$2,000+ per infusion depending on the drug and your supplemental coverage.
If I miss Open Enrollment, can I still enroll in Original Medicare or GUIDE?
Only during General Enrollment (January 1–March 31), and coverage doesn't start until the following month. This delay can be costly if you need immediate dementia care. Missing the October 15–December 7 deadline means waiting at least three months for coverage to begin.
Does my annual wellness visit screen for dementia automatically?
Yes. Cognitive impairment screening is included in every no-cost annual wellness visit for beneficiaries 65+. Ask your doctor to perform it if they don't mention it; if results suggest concern, request the full CPT 99483 cognitive assessment.
